M&A Deal Summary

Thermo Fisher Scientific Acquires Qiagen N.V

On March 3, 2020, Thermo Fisher Scientific acquired life science company Qiagen N.V for 11.5B USD

Acquisition Highlights
  • This is Thermo Fisher Scientific’s 16th transaction in the Life Science sector.
  • This is Thermo Fisher Scientific’s 3rd largest (disclosed) transaction.
  • This is Thermo Fisher Scientific’s 2nd transaction in the Netherlands.

M&A Deal Summary

Date 2020-03-03
Target Qiagen N.V
Sector Life Science
Buyer(s) Thermo Fisher Scientific
Deal Type Add-on Acquisition
Deal Value 11.5B USD
Advisor(s) Goldman Sachs
Barclays Investment Bank (Financial)
De Brauw Blackstone Westbroek N.V
Linklaters
Mintz Levin Cohn Ferris Glovsky and Popeo PC (Legal)

Target

Qiagen N.V

Venlo, Netherlands
QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Qiagen was founded in 1986 and is based in Venlo, the Netherlands.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Thermo Fisher Scientific

Waltham, Massachusetts, United States

Category Company
Founded 1956
Sector Test/Measurement Equipment
Employees122,000
Revenue 42.9B USD (2023)
DESCRIPTION
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.

Thermo Scientific is a provider of analytical instruments, laboratory equipment, software, services, consumables and reagents for better workflow solutions spanning sample preparation, sample analysis, and data interpretation. Thermo Fisher Scientific was founded in 1956 and is based in Waltham, Massachusetts.


DEAL STATS #
Overall 53 of 62
Sector (Life Science) 16 of 23
Type (Add-on Acquisition) 47 of 55
Country (Netherlands) 2 of 2
Year (2020) 1 of 2
Size (of disclosed) 3 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-06 HighChem

Bratislava, Slovakia

HighChem Ltd. is a developer of mass spectrometry software used to analyze complex data and identify small molecules in pharmaceutical and metabolomics laboratories. HighChem is based in Bratislava, Slovakia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-31 Phitonex

Durham, North Carolina, United States

Phitonex, Inc. is a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research. Phitonex was founded in 2017 and is based in Durham, North Carolina.

Buy -